Index · Artikel · Reckitt Benckiser may sell pharmaceuticals business

Reckitt Benckiser may sell pharmaceuticals business

2013-10-22 1
   
Advertisement
résuméLONDON Reckitt Benckiser may sell its pharmaceuticals unit, which has been suffering from declining sales of its main heroin addiction drug, to focus on growing consumer health and household cleaning products businesses. The British consumer goods gr
Advertisement

Reckitt Benckiser may sell pharmaceuticals business


LONDON Reckitt Benckiser may sell its pharmaceuticals unit, which has been suffering from declining sales of its main heroin addiction drug, to focus on growing consumer health and household cleaning products businesses.

The British consumer goods group said on Tuesday it was reviewing options for the pharmaceuticals business, which analysts said could fetch over 2 billion pounds ($3.2 billion) and appeal to international drugmakers.

It also beat third-quarter sales forecasts and nudged up its full-year outlook, signaling it was navigating a slowdown in emerging markets that has hurt rival Unilever.

Reckitt's shares rose more than 5 percent as analysts cheered what they saw as strong performance as well as the possible sale of the pharmaceuticals business, which has been weighing on the stock because of uncertainty over the impact of cheap, generic competition to its addiction drug, Suboxone.

"I think it's a combination of the market seeing a way out of (the pharmaceuticals business) and liking the core story as well," said Investec analyst Martin Deboo.

Third-quarter like-for-like sales excluding Suboxone rose 2 percent in Europe and North America, 10 percent in Latin America and Asia and 5 percent in Russia, the Middle East and Africa.

Four sources familiar with the matter said Reckitt was also considering options for its Scholl footwear business, which sells sandals outside the United States and had about 80 million pounds of sales in 2012, mostly in western and southern Europe.

This would not include its footcare business, which comprises products like insoles and blister bandages, the sources said. Reckitt declined to comment on Scholl.

Reckitt, which makes Dettol disinfectants, Durex condoms and Cillit Bang cleaners, has said it wants to boost its presence in the consumer health sector, which is benefiting from ageing populations in the West and rising incomes in emerging markets.

However, Chief Executive Rakesh Kapoor said the review of the pharmaceuticals unit was being undertaken on its own, and not in conjunction with any other strategic alternatives it may be pursuing.

BEATING FORECASTS

The pharmaceuticals business centers around Suboxone, which Reckitt sells as a film that dissolves in the mouth, used to treat addiction to opioids like heroin. The United States accounts for more than three quarters of Suboxone's sales, which fell 14 percent to 191 million pounds in the third quarter.

Reckitt had said previously that the right time to consider options for the unit would be following the launch of cheap, generic Suboxone tablets. In February, U.S. regulators approved two generic versions of the drug.

Reckitt expects the review to take some time, and said it would update shareholders during the course of 2014.

Finance chief Adrian Hennah stressed all options - including possibly keeping the business - were on the table.

"All options means all options. It doesn't leave anything out," he said.

Analysts said Reckitt would probably end up selling or spinning off the business, potentially using the money to buy another consumer health business. Last year it acquired U.S. vitamins and supplements maker Schiff Nutrition.

Analysts value the unit at between 2 billion and 5.5 billion pounds, with the wide range due in part to the uncertainty over the impact of generic competition on Suboxone.

Reckitt posted a 5 percent rise in third-quarter revenue, which brought year-to-date revenue above analysts' estimates.

For the first nine months of the year, total revenue, excluding the pharmaceuticals business, was 6.95 billion pounds. Analysts on average were expecting 6.93 billion pounds, according to a company-provided consensus.

Looking ahead, the company nudged up its target for full-year net revenue growth, excluding the pharmaceuticals business and including the impact of acquisitions and divestments.

It now sees a rise of at least 6 percent, whereas it earlier forecast growth at the high end of a 5-6 percent range. The firm cited strength of its recent acquisitions for the increase.

(Aditional reporting by Anjuli Davies; Editing by Patrick Lannin and Mark Potter)

TOP

  • Day/
  • Week/
  • Original/
  • Recommand

Updated

  • First Wi-Fi pacemaker in US gives patient freedom

    First Wi-Fi pacemaker in US gives patient freedom
    NEW YORK (Reuters Life!) - After relying on a pacemaker for 20 years, Carol Kasyjanski has become the first American recipient of a wireless pacemaker that allows her doctor to monitor her health from afar -- over the Internet. When Kasyjanski heads
  • Meine inny Bauchnabels ist rot und inflamed.its in einer Falte skin.infected oder Pilz?

    Hat jemand schon einmal gesehen? Ich hatte es nicht bis in letzter Zeit bemerkt, so dass ich weiß nicht, wie lange es so gewesen ist. es ist in einer Hautfalte. vielleicht i Trocknen bin nicht in meinem inny gut genug, so dass es entweder wuchs ein P
  • Langjähriger Leid von Depression, Angstzuständen, Panikattacken, brauchen Beratung. 30 Jahre alt?

    Ich bin 30 Jahre alt. Ich hatte eine Depression Problem meinem ersten Jahr in der Highschool und denken Sie daran denken, was mit mir los ist. Für kurze Zeit nahm ich Zoloft und ich erinnere mich, es zu helfen. Ich erinnere mich an meinen Vater erzäh
  • Ist Ranexa ein Nitrat?

    Ich nehme jetzt Isisorbide und weiß, dass ich keine ED-Medikamente zu nehmen. Würde die Ranexa sicherer? Vielen Dank ----schneiden---- In Antwort auf 2011-03-07 20:00 bis suzanne66 Ranexa ist ein Anti-Angina-pectoris-Medikamente. Es funktioniert durc
  • Ich bin noch einmal über meine Verwendung von Stimulanzien oder Missbrauch zu verwechseln, der weiß, und ist es mir?

    Wie kommt es, dass heute den ganzen Tag ich fantastische Unterstützung und Informationen aus vielen, vielen Mitgliedern hier und war auf Wolke 9 nur bekam für mich eine Person zu erlauben, mich meiner Wolke weg zu klopfen und zu weinen und das Rück m
  • Überraschung zu finden, Hinweise zu Gesundheit der Vegetarians

    Überraschung zu finden, Hinweise zu Gesundheit der Vegetarians
    Credit: Marta Sobo | Stock.xchng Vegetarians 36 Prozent weniger wahrscheinlich sind das metabolische Syndrom zu haben als Nicht-Vegetarier, schlägt eine neue Studie. Und weil das metabolische Syndrom ein Vorläufer zur Herzkrankheit sein kann, Diabete
  • Die Macht der Wahl Resilience

    Die Macht der Wahl Resilience
    Psychologische Bedingungen , die Epidemie unter den städtischen homo- und bisexuelle Jugendliche Warrant bewusste Anstrengungen sind Selbstwertgefühl, positive Beziehungen zu fördern und soziale Unterstützung. Aaron Favila / AP "Er würde in einen Rau
  • Was ist "Flight of Ideas" in Bipolar Disorder?

    Was ist "Flight of Ideas" in Bipolar Disorder?
    Was sind rasende Gedanken und Flüge der Ideen? Während einer bipolaren Störung wird im allgemeinen als eine affektive Störung betrachtet, Symptome - vor allem während der manischen Episoden - auch können Störungen des Denkens gehören. Menschen in ein
  • Smoking in pregnancy tied to kids' conduct problems

    Smoking in pregnancy tied to kids' conduct problems
    NEW YORK (Reuters Health) - Children of women who smoked cigarettes during pregnancy are more likely to have behavioral problems than those whose mothers didn't light up, says a new analysis. "The evidence is emerging that smoking in pregnancy and th
  • Kaufen Sie Arzneimittel und Medizinprodukte Online

    Kaufen Sie Arzneimittel und Medizinprodukte Online
    Mit Hunderten von Medikament abgebenden Websites in der Wirtschaft, wie können die Verbraucher erkennen, welche Websites sind legitim sind, vor allem wenn es sehr einfach ist, eine Website einzurichten, ist sehr professionell aussehende und versprich